Toll Free: 1-888-928-9744

OncoTherapy Science, Inc. - Product Pipeline Review - 2014

Published: Jul, 2014 | Pages: 36 | Publisher: Global Markets Direct
Industry: Pharmaceutical | Report Format: Electronic (PDF)

OncoTherapy Science, Inc. - Product Pipeline Review - 2014

Summary

Global Markets Direct's, 'OncoTherapy Science, Inc. - Product Pipeline Review - 2014', provides an overview of the OncoTherapy Science, Inc.'s pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of OncoTherapy Science, Inc.'s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides brief overview of OncoTherapy Science, Inc. including business description, key information and facts, and its locations and subsidiaries
- The report reviews current pipeline of OncoTherapy Science, Inc.'s human therapeutic division and enlists all their major and minor projects
- The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones 
- Special feature on out-licensed and partnered product portfolio
- The report summarizes all the dormant and discontinued pipeline projects
- Latest company statement 
- Latest news and deals relating to the OncoTherapy Science, Inc.'s pipeline products

Reasons to buy

- Evaluate OncoTherapy Science, Inc.'s strategic position with total access to detailed information on its product pipeline
- Assess the growth potential of OncoTherapy Science, Inc. in its therapy areas of focus
- Identify new drug targets and therapeutic classes in the OncoTherapy Science, Inc.'s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
- Develop strategic initiatives by understanding the focus areas of OncoTherapy Science, Inc. and exploit collaboration and partnership opportunities
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Plan mergers and acquisitions effectively by identifying the most promising pipeline of OncoTherapy Science, Inc.
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
- Explore the dormant and discontinued projects of OncoTherapy Science, Inc. and identify potential opportunities in those areas
- Avoid Intellectual Property Rights related issues
 Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 4
OncoTherapy Science, Inc. Snapshot 5
OncoTherapy Science, Inc. Overview 5
Key Information 5
Key Facts 5
OncoTherapy Science, Inc. - Research and Development Overview 6
Key Therapeutic Areas 6
OncoTherapy Science, Inc. - Pipeline Review 9
Pipeline Products by Stage of Development 9
Pipeline Products - Monotherapy 10
Pipeline Products - Partnered Products 11
Partnered Products/Combination Treatment Modalities 12
Pipeline Products - Out-Licensed Products 13
Out-Licensed Products/Combination Treatment Modalities 14
OncoTherapy Science, Inc. - Pipeline Products Glance 15
OncoTherapy Science, Inc. - Clinical Stage Pipeline Products 15
Phase II Products/Combination Treatment Modalities 15
Phase I Products/Combination Treatment Modalities 16
OncoTherapy Science, Inc. - Early Stage Pipeline Products 17
Preclinical Products/Combination Treatment Modalities 17
OncoTherapy Science, Inc. - Drug Profiles 18
elpamotide 18
Product Description 18
Mechanism of Action 18
R&D Progress 18
OCV-C01 20
Product Description 20
Mechanism of Action 20
R&D Progress 20
OTSGC-A24 21
Product Description 21
Mechanism of Action 21
R&D Progress 21
NCV-01 22
Product Description 22
Mechanism of Action 22
R&D Progress 22
ONO-7268MX1 23
Product Description 23
Mechanism of Action 23
R&D Progress 23
ONO-7268MX2 24
Product Description 24
Mechanism of Action 24
R&D Progress 24
OTS-167 25
Product Description 25
Mechanism of Action 25
R&D Progress 25
OTSA-101 26
Product Description 26
Mechanism of Action 26
R&D Progress 26
OTS-964 27
Product Description 27
Mechanism of Action 27
R&D Progress 27
OncoTherapy Science, Inc. - Pipeline Analysis 28
OncoTherapy Science, Inc. - Pipeline Products by Target 28
OncoTherapy Science, Inc. - Pipeline Products by Route of Administration 29
OncoTherapy Science, Inc. - Pipeline Products by Molecule Type 30
OncoTherapy Science, Inc. - Pipeline Products by Mechanism of Action 31
OncoTherapy Science, Inc. - Recent Pipeline Updates 32
OncoTherapy Science, Inc. - Dormant Projects 33
OncoTherapy Science, Inc. - Locations And Subsidiaries 34
Head Office 34
Other Locations & Subsidiaries 34
Appendix 35
Methodology 35
Coverage 35
Secondary Research 35
Primary Research 35
Expert Panel Validation 35
Contact Us 36
Disclaimer 36
List of Tables
OncoTherapy Science, Inc., Key Information 5
OncoTherapy Science, Inc., Key Facts 5
OncoTherapy Science, Inc. - Pipeline by Indication, 2014 8
OncoTherapy Science, Inc. - Pipeline by Stage of Development, 2014 9
OncoTherapy Science, Inc. - Monotherapy Products in Pipeline, 2014 10
OncoTherapy Science, Inc. - Partnered Products in Pipeline, 2014 11
OncoTherapy Science, Inc. - Partnered Products/ Combination Treatment Modalities, 2014 12
OncoTherapy Science, Inc. - Out-Licensed Products in Pipeline, 2014 13
OncoTherapy Science, Inc. - Out-Licensed Products/ Combination Treatment Modalities, 2014 14
OncoTherapy Science, Inc. - Phase II, 2014 15
OncoTherapy Science, Inc. - Phase I, 2014 16
OncoTherapy Science, Inc. - Preclinical, 2014 17
OncoTherapy Science, Inc. - Pipeline by Target, 2014 28
OncoTherapy Science, Inc. - Pipeline by Route of Administration, 2014 29
OncoTherapy Science, Inc. - Pipeline by Molecule Type, 2014 30
OncoTherapy Science, Inc. - Pipeline Products by Mechanism of Action, 2014 31
OncoTherapy Science, Inc. - Recent Pipeline Updates, 2014 32
OncoTherapy Science, Inc. - Dormant Developmental Projects,2014 33
OncoTherapy Science, Inc., Subsidiaries 34 



                                

To request a free sample copy of this report, please complete the form below.

We never share your personal data. Privacy policy
Interested in this report? Get your FREE sample now! Get a Free Sample
Choose License Type
Single User - US $1500
Multi User - US $3000
Hexareeasearch Know

Did you know?

Research Assistance

Phone: 1-415-349-0054

Toll Free: 1-888-928-9744

Email: [email protected]

Why to buy from us

Custom research service

Speak to the report author to design an exclusive study to serve your research needs.

Information security

Your personal and confidential information is safe and secure.

verify